Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.35 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | THRA | P10827 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21990592 | 0.94 | TDP1 (0.60) | TDP1MCHR1KCNH2SERPINE1VCAM1 | |
| Trolamine SCHEMBL3410426 | 0.83 | TDP1 (0.70) | TDP1POLBSMN1; SMN2LMNAVCAM1 | |
| Tetrabuthylammonium SCHEMBL7765608 | 0.82 | TDP1 (0.64) | TDP1SMN1; SMN2KCNH2TAS1R3TAS1R1 | |
| SCHEMBL27165608 | 0.82 | TDP1 (0.64) | TDP1POLBSMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL11867695 | 0.81 | SMN1; SMN2 (0.50) | TDP1ESR1POLBSMN1; SMN2LMNA | |
| Phenolsulfonic Acid SCHEMBL28556276 | 0.81 | LMNA (0.59) | TDP1MCHR1ESR1POLBSMN1; SMN2 | |
| SCHEMBL5874555 | 0.81 | MCHR1 (0.58) | TDP1MCHR1SMN1; SMN2KCNH2LMNA | |
| Octadecylamine SCHEMBL9548499 | 0.81 | TDP1 (0.62) | TDP1S1PR3CA12CA1CA2 | |
| SCHEMBL21990522 | 0.81 | TDP1 (0.62) | TDP1S1PR3CA12CA1CA2 | |
| SCHEMBL29104437 | 0.80 | TDP1 (0.78) | TDP1POLBSMN1; SMN2TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3395422-B1 | REMOVAL OF METAL IONS FROM ESSENTIAL OILS | BIOTAGE AB (SE) | 2022-01-26 | — | — | EP | disclosed |
| US-10920171-B2 | Removal of metal ions from essential oils | BIOTAGE AB (SE) | 2021-02-16 | — | — | US | disclosed |
| US-20200131452-A1 | REMOVAL OF METAL IONS FROM ESSENTIAL OILS | BIOTAGE AB (SE) | 2020-04-30 | — | — | US | disclosed |
| CN-110662591-A | Removal of metal ions from essential oils | 百特基公司 | 2020-01-07 | — | — | CN | disclosed |
| EP-3395422-A1 | REMOVAL OF METAL IONS FROM ESSENTIAL OILS | Biotage AB (SE) | 2018-10-31 | — | — | EP | disclosed |
| US-10023714-B2 | Porous polymeric separation material | BIOTAGE AB (SE) | 2018-07-17 | — | — | US | disclosed |
| EP-2432588-B1 | POROUS POLYMERIC SEPARATION MATERIAL | BIOTAGE AB (SE) | 2017-01-18 | — | — | EP | disclosed |
| US-20170009041-A1 | POROUS POLYMERIC SEPARATION MATERIAL | BIOTAGE AB | 2017-01-12 | — | — | US | disclosed |
| CN-102802782-B | Porous polymeric separation materials | BIOTAGE AB | 2015-05-13 | — | — | CN | disclosed |
| CN-102802782-A | Porous polymeric separation materials | MIP TECHNOLOGIES AB | 2012-11-28 | — | — | CN | disclosed |
| WO-2010134877-A1 | POROUS POLYMERIC SEPARATION MATERIAL | MIP TECHNOLOGIES AB (SE) | 2010-11-25 | — | — | WO | disclosed |
| US-20070093568-A1 | Organic polymer materials having sulfonic acid groups and method for their preparation | EBARA CORPORATION (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-0613468-B1 | Substituted salicylic acids for the treatment of autoimmune diseases | PHARMACIA & UPJOHN AB (SE) | 2000-07-12 | — | — | EP | disclosed |
| CN-1042631-C | Novel substituted salicylic acids | KABI PHARMACIA AB (SE) | 1999-03-24 | — | — | CN | disclosed |
| US-5556855-A | TREATMENT OF AUTOIMMUNE DISEASES | PHARMACIA AB (SE) | 1996-09-17 | — | — | US | disclosed |
| US-5403930-A | Chemical intermediate for drugs used in autoimmune diseases | PHARMACIA AB (SE) | 1995-04-04 | — | — | US | disclosed |
| EP-0613468-A1 | NOVEL SUBSTITUTED SALICYCLIC ACIDS | Pharmacia & Upjohn Aktiebolag (SE) | 1994-09-07 | — | — | EP | disclosed |
| CN-1088918-A | The salicylic acid compounds of new replacement | KABI PHARMACIA AB (SE) | 1994-07-06 | — | — | CN | disclosed |
| US-5302718-A | Used for treating autoimmune diseases | KABI PHARMACIA AB (SE) | 1994-04-12 | — | — | US | disclosed |
| WO-1993010094-A1 | NOVEL SUBSTITUTED SALICYCLIC ACIDS | KABI PHARMACIA AB (SE) | 1993-05-27 | — | — | WO | disclosed |